Posted on Monday, February 03, 2014 at 9:15 am CST
Global Market Direct's pharmaceuticals report, "High Point Pharmaceuticals, LLC - Product Pipeline Review - 2013" provides data on the High Point Pharmaceuticals, LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:15 am CST
Global Market Direct's pharmaceuticals report, "Akron Molecules GmbH - Product Pipeline Review - 2013" provides data on the Akron Molecules GmbH's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:15 am CST
Global Market Direct's pharmaceuticals report, "Proacta, Inc. - Product Pipeline Review - 2013" provides data on the Proacta, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:15 am CST
Global Market Direct's pharmaceuticals report, "nLife Therapeutics, S.L. - Product Pipeline Review - 2013" provides data on the nLife Therapeutics, S.L.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:15 am CST
Global Markets Direct's, 'Arterial Thrombosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Arterial Thrombosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Arterial Thrombosis. Arterial Thrombosis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:15 am CST
Global Markets Direct's, 'Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome). Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:15 am CST
Global Market Direct's pharmaceuticals report, "Stemline Therapeutics, Inc. - Product Pipeline Review - 2013" provides data on the Stemline Therapeutics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:15 am CST
Global Market Direct's pharmaceuticals report, "Synbody Biotechnology, Inc. - Product Pipeline Review - 2013" provides data on the Synbody Biotechnology, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:15 am CST
Global Market Direct's pharmaceuticals report, "Abeille Pharmaceuticals, Inc. - Product Pipeline Review - 2013" provides data on the Abeille Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:00 am CST
Global Market Direct's pharmaceuticals report, "GlycoVaxyn AG - Product Pipeline Review - 2013" provides data on the GlycoVaxyn AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:00 am CST
Global Markets Direct's, 'Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Allergic Rhino-Conjunctivitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Allergic Rhino-Conjunctivitis. Allergic Rhino-Conjunctivitis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:00 am CST
Global Markets Direct's, 'Cellulite - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cellulite, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cellulite. Cellulite - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:00 am CST
Global Market Direct's pharmaceuticals report, "GinkgoPharma Co. Ltd. - Product Pipeline Review - 2013" provides data on the GinkgoPharma Co. Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:00 am CST
The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through adulthood. However, the burden on patients and their families to maintain the prophylactic treatment schedule is high, and there is a significant unmet need for new therapies that can reduce the number of weekly prophylactic infusions and alleviate some of this treatment burden.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:00 am CST
Global Market Direct's pharmaceuticals report, "Foresee Pharmaceuticals, LLC - Product Pipeline Review - 2013" provides data on the Foresee Pharmaceuticals, LLC's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:00 am CST
Global Markets Direct's, 'Hypoglycemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Hypoglycemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypoglycemia. Hypoglycemia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 9:00 am CST
Global Market Direct's pharmaceuticals report, "Maruishi Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013" provides data on the Maruishi Pharmaceutical Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 8:45 am CST
Global Market Direct's pharmaceuticals report, "Artielle ImmunoTherapeutics, Inc. - Product Pipeline Review - 2013" provides data on the Artielle ImmunoTherapeutics, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 8:45 am CST
Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 8:45 am CST
Global Market Direct's pharmaceuticals report, "Zambon Company S.p.A. - Product Pipeline Review - 2013" provides data on the Zambon Company S.p.A.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 8:45 am CST
Global Market Direct's pharmaceuticals report, "Almac Discovery Ltd. - Product Pipeline Review - 2013" provides data on the Almac Discovery Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 8:45 am CST
Global Market Direct's pharmaceuticals report, "Relevare Pharmaceuticals Ltd. - Product Pipeline Review - 2013" provides data on the Relevare Pharmaceuticals Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 8:45 am CST
Global Market Direct's pharmaceuticals report, "XTL Biopharmaceuticals Ltd. - Product Pipeline Review - 2013" provides data on the XTL Biopharmaceuticals Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 8:45 am CST
Global Market Direct's pharmaceuticals report, "M et P Pharma AG - Product Pipeline Review - 2013" provides data on the M et P Pharma AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research
Posted on Monday, February 03, 2014 at 8:45 am CST
Global Market Direct's pharmaceuticals report, "MediciNova, Inc. - Product Pipeline Review - 2013" provides data on the MediciNova, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
Source: Fast Market Research